Drug:
Reaction: WEIGHT INCREASED
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26545824 |
|||
Weight increased, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 202 | 26546581 |
|||
Weight increased, |
||||
RISPERIDONE, |
||||
| 203 | 26554303 |
|||
Weight increased, |
||||
SERTRALINE, |
||||
| 204 | 26531214 |
PR |
41 | 2 |
Cholelithiasis, Psoriasis, Uterine polyp, Anxiety, Depression, Blood cholesterol increased, Nail discolouration, Weight increased, Hypometabolism, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, ESCITALOPRAM, |
||||
| 205 | 26531654 |
US |
2 | |
Weight increased, |
||||
TROFINETIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 206 | 26531837 |
US |
59 | 1 |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 207 | 26531857 |
EU |
30 | 2 |
Blood magnesium decreased, Low density lipoprotein increased, Weight increased, Oedema, Paraesthesia, Hirsutism, Blood cholesterol increased, Off label use, |
||||
CYCLOSPORINE, MESALAMINE, PREDNISONE, CEFUROXIME, |
||||
| 208 | 26532279 |
US |
66 | 2 |
Weight increased, |
||||
UPADACITINIB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PREDNISONE, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 209 | 26533132 |
US |
53 | 1 |
Weight increased, Lethargy, |
||||
TIRZEPATIDE, |
||||
| 210 | 26533135 |
US |
78 | 2 |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 211 | 26533640 |
BR |
19 | 1 |
Weight increased, Inappropriate schedule of product administration, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 212 | 26533996 |
US |
25 | 1 |
Thrombosis, Blood triglycerides increased, Blood cholesterol increased, Weight increased, Increased appetite, Paraesthesia, Disturbance in attention, Headache, |
||||
LORLATINIB, LORLATINIB, |
||||
| 213 | 26534023 |
CA |
42 | 2 |
Ankylosing spondylitis, Weight increased, Nausea, Nasopharyngitis, Dizziness, Therapeutic product effect incomplete, Off label use, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 214 | 26534389 |
US |
70 | 2 |
Off label use, Drug interaction, Weight increased, Drug ineffective, |
||||
INSULIN HUMAN, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN LISPRO, |
||||
| 215 | 26534521 |
CN |
67 | 1 |
Osteonecrosis, Weight increased, Off label use, |
||||
METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 216 | 26534591 |
65 | 2 | |
Carcinoid tumour, Thyroid mass, Pulmonary mass, Alopecia, Weight increased, |
||||
MAVACAMTEN, |
||||
| 217 | 26534634 |
US |
68 | 2 |
Weight increased, |
||||
DUPILUMAB, |
||||
| 218 | 26535144 |
US |
||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 219 | 26535191 |
US |
70 | |
Weight increased, Dry skin, Onychoclasis, Feeling cold, Nail ridging, Stress, Blood thyroid stimulating hormone abnormal, Tri-iodothyronine free abnormal, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 220 | 26535242 |
EU |
40 | 2 |
Thrombocytopenia, Lymphadenopathy, Weight increased, Headache, Haemoglobin decreased, Psoriasis, Red blood cell sedimentation rate increased, Drug ineffective, Drug intolerance, Skin disorder, |
||||
METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, TOFACITINIB, ABATACEPT, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE, AMLODIPINE, BARICITINIB, |
||||
| 221 | 26535385 |
US |
20 | 1 |
Weight increased, Blood glucose increased, Fluid retention, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, SOMATROPIN, LEVOCARNITINE, LEVOCARNITINE ORAL, PREDNISONE, TESTOSTERONE ENANTHATE, |
||||
| 222 | 26535390 |
US |
1 | |
Herpes virus infection, Weight increased, |
||||
VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 223 | 26527230 |
US |
45 | 1 |
Drug ineffective, Weight increased, Increased appetite, |
||||
TIRZEPATIDE, |
||||
| 224 | 26527273 |
US |
1 | |
Weight increased, Dyspnoea, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMBRISENTAN, |
||||
| 225 | 26527355 |
CA |
40 | 2 |
Breast cancer stage III, Gait inability, Exposure during pregnancy, Vomiting, Musculoskeletal stiffness, Depression, Hand deformity, Pneumonia, Back injury, Abdominal distension, Weight increased, Dry mouth, Off label use, Blepharospasm, General physical health deterioration, Intentional product use issue, Dizziness, Duodenal ulcer perforation, Muscular weakness, Swelling, Facet joint syndrome, Asthenia, Nasopharyngitis, Hypercholesterolaemia, Blister, Neck pain, Gastrooesophageal reflux disease, Wound infection, Product label confusion, Pain in extremity, Synovitis, Wheezing, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, USTEKINUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, BOTULINUM TOXIN TYPE A, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, CALCIUM CARBONATE, CANDESARTAN, ERGOCALCIFEROL, BUPRENORPHINE, BUPRENORPHINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, OXYCODONE, OXYCODONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 226 | 26527587 |
US |
2 | |
Weight increased, Eating disorder, Headache, Dry mouth, Constipation, Abdominal pain upper, Nausea, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 227 | 26527694 |
US |
41 | 2 |
Weight increased, Increased appetite, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 228 | 26528311 |
|||
Self-destructive behaviour, Dependent personality disorder, Affect lability, Depression, Anxiety, Weight increased, Drug interaction, Drug ineffective, |
||||
QUETIAPINE, OLANZAPINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LITHIUM, LITHIUM BROMATUM, VORTIOXETINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, SERTRALINE, |
||||
| 229 | 26528456 |
US |
71 | 2 |
Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 230 | 26528608 |
2 | ||
Blood uric acid increased, Weight increased, Myalgia, Fatigue, Swelling, Gout, Sleep apnoea syndrome, Increased appetite, Constipation, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 231 | 26528905 |
EU |
2 | |
Diabetic metabolic decompensation, Migraine, Asthenia, Weight increased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 232 | 26529494 |
33 | 2 | |
Weight increased, Breast cyst, |
||||
LEVONORGESTREL, |
||||
| 233 | 26529786 |
GB |
25 | 2 |
Rosacea, Hypotension, Hypertension, Dizziness, Loss of consciousness, Chest pain, Hyperhidrosis, Weight increased, |
||||
SERTRALINE, SERTRALINE, |
||||
| 234 | 26529903 |
US |
24 | 2 |
Electrocardiogram QT prolonged, Trichotillomania, Madarosis, Chest discomfort, Cough, Dyspnoea, Dysphonia, Fatigue, Wheezing, Hypoacusis, Pain, Chest pain, Pyrexia, Rhinitis, Haemoptysis, Tinnitus, Hypoglycaemia, Alanine aminotransferase increased, Non-pitting oedema, Headache, Hypertension, Flushing, Flushing, Menstruation irregular, Weight increased, Oropharyngeal pain, Tinnitus, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AMIKACIN, AMIKACIN, |
||||
| 235 | 26530263 |
US |
26 | 2 |
Weight increased, Proteinuria, |
||||
PREDNISONE, VOCLOSPORIN, |
||||
| 236 | 26530338 |
US |
||
Weight increased, Intermenstrual bleeding, |
||||
DROSPIRENONE, DROSPIRENONE, |
||||
| 237 | 26530405 |
US |
82 | |
Weight increased, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
| 238 | 26530507 |
US |
2 | |
Injection site bruising, Pain, Weight increased, Skin striae, Contusion, |
||||
ASFOTASE ALFA, |
||||
| 239 | 26530525 |
AU |
42 | 2 |
Subcutaneous abscess, Weight increased, Vulvovaginal candidiasis, Emotional distress, Food craving, Dyspepsia, Vomiting, Bone density decreased, Dehydration, Muscle atrophy, Muscular weakness, Nausea, Hyperglycaemia, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SITAGLIPTIN, |
||||
| 240 | 26530547 |
JP |
77 | 1 |
Bronchopulmonary aspergillosis, Dementia, Weight increased, |
||||
AVACOPAN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 241 | 26530556 |
US |
75 | 2 |
Off label use, Hunger, Weight increased, Nausea, Injection site reaction, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 242 | 26530597 |
US |
1 | |
Respiratory distress, Dyspnoea, Weight increased, |
||||
IDURSULFASE, ACETAMINOPHEN, CHILDRENS PAIN RELIEF, |
||||
| 243 | 26530598 |
EU |
76 | 1 |
Erectile dysfunction, Micturition urgency, Loss of libido, Weight increased, Dizziness, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, |
||||
| 244 | 26530670 |
EU |
2 | |
Pneumonia, Atrial fibrillation, Hypotension, Fluid retention, Weight increased, Blood pressure diastolic increased, |
||||
SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, |
||||
| 245 | 26530784 |
US |
73 | 1 |
Inappropriate schedule of product administration, Food craving, Increased appetite, Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 246 | 26530798 |
1 | ||
Therapeutic response unexpected, Memory impairment, Disturbance in attention, Feeling drunk, Motor dysfunction, Lethargy, Weight increased, |
||||
OLANZAPINE AND SAMIDORPHAN L-MALATE, DARIDOREXANT, OLANZAPINE, |
||||
| 247 | 26533193 |
1 | ||
Fluid retention, Peripheral swelling, Peripheral swelling, Weight increased, Joint swelling, |
||||
SOTATERCEPT-CSRK, |
||||
| 248 | 26533671 |
75 | 2 | |
Vomiting, Hypersensitivity, Reaction to excipient, Gastrointestinal disorder, Fear, Therapy cessation, Weight increased, |
||||
TIRZEPATIDE, ATORVASTATIN CALCIUM, VITAMIN C, |
||||
| 249 | 26522654 |
CA |
2 | |
Weight increased, Wheezing, Wound, Wound infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 250 | 26522684 |
US |
59 | 1 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 251 | 26522975 |
US |
61 | 2 |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 252 | 26523047 |
US |
71 | 2 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 253 | 26523048 |
US |
68 | 2 |
Headache, Injection site erythema, Injection site rash, Injection site pruritus, Weight increased, Off label use, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 254 | 26523102 |
JP |
65 | 1 |
Diabetes mellitus inadequate control, Muscle atrophy, Grip strength decreased, Fine motor skill dysfunction, Bradykinesia, Weight increased, Fat tissue increased, Off label use, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 255 | 26523209 |
US |
2 | |
Intermenstrual bleeding, Breast enlargement, Hunger, Weight increased, Malabsorption, Brain fog, Fatigue, |
||||
ESTRADIOL, PROGESTERONE, |
||||
| 256 | 26523273 |
CA |
43 | 2 |
Sleep disorder, Sinusitis, Sciatica, Road traffic accident, Rheumatoid arthritis, Rheumatic fever, Respiratory disorder, Red blood cell sedimentation rate increased, Rectal haemorrhage, Rash, Psoriatic arthropathy, Porphyria acute, Pneumonia, Peripheral venous disease, Peripheral swelling, Pericarditis, Pemphigus, Paraesthesia, Pancreatitis, Pain in extremity, Pain, Overlap syndrome, Osteoarthritis, Onychomycosis, Onychomadesis, Oedema peripheral, Normal newborn, Obesity, Night sweats, Neck pain, Nasopharyngitis, Nail disorder, Musculoskeletal pain, Muscular weakness, Muscle spasms, Muscle injury, Mobility decreased, Migraine, Memory impairment, Lupus-like syndrome, Lung disorder, Lower respiratory tract infection, Lower limb fracture, Swelling, Liver injury, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Ulcer haemorrhage, Underdose, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, Abdominal discomfort, X-ray abnormal, Stomatitis, Therapeutic product effect incomplete, Treatment failure, Therapy non-responder, Therapeutic product effect decreased, Maternal exposure during pregnancy, Product use issue, Off label use, Product use in unapproved indication, Product quality issue, Prescribed underdose, |
||||
CANDESARTAN, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, ALENDRONATE SODIUM, |
||||
| 257 | 26523339 |
US |
80 | 2 |
Fluid retention, Pain, Weight increased, |
||||
MAVACAMTEN, TORSEMIDE, TORSEMIDE, |
||||
| 258 | 26523555 |
US |
72 | 1 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 259 | 26523656 |
US |
76 | 2 |
Glaucoma, Visual impairment, Thyroid disorder, Weight increased, Inflammation, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 260 | 26523937 |
US |
54 | 2 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, |
||||
| 261 | 26524368 |
CA |
40 | 2 |
Abdominal distension, Asthenia, Back injury, Blepharospasm, Blister, Breast cancer stage III, Depression, Dizziness, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Hand deformity, Hypercholesterolaemia, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Neck pain, Pain in extremity, Pneumonia, Swelling, Synovitis, Vomiting, Wound infection, Weight increased, Wheezing, Exposure during pregnancy, Product label confusion, Intentional product use issue, Off label use, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, USTEKINUMAB, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ERGOCALCIFEROL, CALCIUM CARBONATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, NAPROXEN, NAPROXEN SODIUM, |
||||
| 262 | 26524447 |
EU |
2 | |
Type 2 diabetes mellitus, Metabolic dysfunction-associated liver disease, Hypercholesterolaemia, Fatigue, Arthralgia, Peripheral swelling, Fluid retention, Weight increased, Sleep disorder, Hyperhidrosis, |
||||
| 263 | 26524522 |
CA |
43 | 2 |
Systemic lupus erythematosus, Rheumatoid arthritis, Vomiting, Peripheral venous disease, Weight increased, Maternal exposure during pregnancy, Psoriatic arthropathy, Product use in unapproved indication, Wheezing, Pemphigus, Product quality issue, Swelling, Exposure during pregnancy, Pain, Wound infection, Stomatitis, Urticaria, Wound, Rash, Paraesthesia, Synovitis, Pericarditis, Peripheral swelling, Taste disorder, Type 2 diabetes mellitus, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, ERENUMAB-AOOE, ERENUMAB-AOOE, RITUXIMAB, MAGNESIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, PREDNISONE, TOFACITINIB CITRATE, CANDESARTAN, GOLIMUMAB, GOLIMUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, OXYCODONE, TOFACITINIB, TOFACITINIB CITRATE, SECUKINUMAB, SECUKINUMAB, LORAZEPAM, LISINOPRIL, SULFASALAZINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RISEDRONATE SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 264 | 26524555 |
US |
72 | 2 |
Foreign body in throat, Illness, Weight increased, Abdominal discomfort, Vomiting, Eructation, Nausea, Abdominal pain upper, |
||||
SEMAGLUTIDE, |
||||
| 265 | 26525135 |
US |
73 | 2 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 266 | 26525460 |
US |
69 | 2 |
Incorrect dose administered, Joint noise, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 267 | 26525527 |
US |
2 | |
Nephrolithiasis, Kidney infection, Urinary tract infection, Weight increased, Cystitis interstitial, Condition aggravated, Off label use, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 268 | 26525728 |
CA |
43 | 2 |
Pain, Peripheral venous disease, Paraesthesia, Pemphigus, Peripheral swelling, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Pericarditis, Maternal exposure during pregnancy, Exposure during pregnancy, Product quality issue, Product use in unapproved indication, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE, RITUXIMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOPIRAMATE, TOPIRAMATE SPINKLE, SECUKINUMAB, SECUKINUMAB, PREDNISONE, ERENUMAB-AOOE, ERENUMAB-AOOE, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, LORAZEPAM, RISEDRONATE SODIUM, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LISINOPRIL, |
||||
| 269 | 26525926 |
US |
||
Weight increased, Blood glucose abnormal, |
||||
TIRZEPATIDE, |
||||
| 270 | 26526060 |
US |
2 | |
Spondylitis, Spinal stenosis, Oedema peripheral, Weight increased, Joint stiffness, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, NAPROXEN, NAPROXEN SODIUM, |
||||
| 271 | 26526209 |
US |
55 | 2 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, |
||||
| 272 | 26526265 |
US |
65 | 1 |
Weight increased, Peripheral swelling, Left ventricular outflow tract gradient increased, |
||||
MAVACAMTEN, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 273 | 26526278 |
US |
2 | |
Complication associated with device, Bacterial infection, Weight increased, |
||||
SEMAGLUTIDE, |
||||
| 274 | 26526398 |
US |
2 | |
Dehydration, Blood creatinine abnormal, Weight increased, Hypophagia, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, TADALAFIL, |
||||
| 275 | 26526422 |
US |
65 | 1 |
Arthralgia, Gout, Pain in extremity, Fluid retention, Weight increased, |
||||
LORLATINIB, LORLATINIB, |
||||
| 276 | 26526482 |
US |
||
Weight increased, Hunger, Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 277 | 26526495 |
US |
50 | 2 |
Gastrooesophageal reflux disease, Fatigue, Pharyngeal inflammation, Throat lesion, Stomatitis, Condition aggravated, Swelling, Pain, Discomfort, Weight increased, Feeding disorder, Dysphagia, |
||||
PALBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 278 | 26526500 |
US |
75 | 1 |
Weight increased, Increased appetite, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 279 | 26526550 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREPITANT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, HYDROCORTISONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, LEFLUNOMIDE, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 280 | 26526574 |
JP |
47 | 2 |
Oedema, Weight increased, Arthralgia, Cushingoid, Dermatitis acneiform, Nasopharyngitis, Pyrexia, Cough, Insomnia, Oxygen saturation decreased, Bronchitis, Feeling abnormal, Seasonal allergy, Hot flush, Flushing, Nausea, Nausea, Malaise, Malaise, Headache, Vomiting, Hot flush, Dyspnoea, Pain in extremity, Rash, Dizziness, Blood pressure systolic decreased, Dizziness, |
||||
TADALAFIL, TADALAFIL, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, MACITENTAN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, SPIRONOLACTONE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 281 | 26526580 |
US |
1 | |
Weight increased, Limb injury, Fall, Injection site reaction, Therapeutic response shortened, Ankle fracture, Arthralgia, |
||||
NUSINERSEN, |
||||
| 282 | 26522266 |
US |
2 | |
Weight increased, Product dose omission in error, |
||||
ELIGLUSTAT, |
||||
| 283 | 26522331 |
US |
39 | 1 |
Product dose omission issue, Weight increased, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 284 | 26522339 |
US |
67 | 1 |
Gastrointestinal hypomotility, Weight increased, Drug ineffective, Food craving, Gastrointestinal sounds abnormal, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 285 | 26522360 |
US |
73 | 1 |
Rectal haemorrhage, Drug ineffective, Weight increased, Constipation, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 286 | 26522361 |
US |
69 | 2 |
Weight increased, Abdominal pain upper, Diarrhoea, Vomiting, Eructation, Constipation, Feeling abnormal, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 287 | 26522402 |
US |
47 | 2 |
Product dispensing error, Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 288 | 26522507 |
US |
||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 289 | 26521310 |
US |
75 | 2 |
Weight increased, Nasopharyngitis, Illness, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 290 | 26521572 |
US |
2 | |
Feeling abnormal, Brain fog, Hyperhidrosis, Swelling, Weight increased, Blood cholesterol, Blood glucose fluctuation, Renal pain, Follicular lymphoma, Lung disorder, Bronchitis, Pneumonia, Pruritus, Headache, Brain fog, |
||||
TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, |
||||
| 291 | 26521697 |
US |
2 | |
Bone pain, Weight increased, Glycosylated haemoglobin decreased, |
||||
DOSTARLIMAB, |
||||
| 292 | 26521734 |
US |
||
Diarrhoea, Weight increased, |
||||
RISPERIDONE, |
||||
| 293 | 26521831 |
US |
1 | |
Weight increased, Drug half-life reduced, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
| 294 | 26517001 |
CA |
44 | 2 |
Rash, Pruritus, Pyrexia, Drug hypersensitivity, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Blister, Decreased appetite, Discomfort, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, VITAMIN C, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, SECUKINUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, |
||||
| 295 | 26517032 |
US |
21 | 1 |
Weight increased, Cushingoid, Off label use, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, GABAPENTIN, GABAPENTIN, |
||||
| 296 | 26517224 |
EU |
2 | |
Death, Weight increased, Oedema peripheral, Drug interaction, Insomnia, Somnolence, |
||||
PREGABALIN, PREGABALIN, OXYCODONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, FUROSEMIDE, MORPHINE, TOPIRAMATE, TOPIRAMATE SPINKLE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, GABAPENTIN, GABAPENTIN, |
||||
| 297 | 26517226 |
US |
1 | |
Arrhythmia, Weight increased, |
||||
FINASTERIDE, |
||||
| 298 | 26517473 |
74 | ||
Exposure to toxic agent, Glycosylated haemoglobin increased, Weight increased, Therapy interrupted, Intentional product misuse, Product availability issue, |
||||
INSULIN ASPART, INSULIN GLARGINE, |
||||
| 299 | 26517505 |
US |
67 | 2 |
Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 300 | 26517850 |
CA |
||
Weight increased, Wheezing, Wound, Wound infection, |
||||
MESALAMINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, ALENDRONATE SODIUM, APREMILAST, APREMILAST, APREMILAST, CLONIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28